Health
FDA Seeks Public Input to Support Ibogaine Research
Source: U.S. Food and Drug Administration (FDA)
Published:
Source summary — U.S. Food and Drug Administration (FDA)
The U.S. Food and Drug Administration today announced a request for information (RFI) describing approaches the agency is considering for the design of early-phase clinical trials of ibogaine drug products and seeking public input on those approaches.
This page reports what the publisher stated. MYITEDU has not independently verified these claims.
Read the original article — U.S. Food and Drug Administration (FDA) ↗
Attribution: Source: U.S. Food and Drug Administration (fda.gov)
Share
Instagram does not support sharing links from websites. Download the card, post it from the Instagram app and paste the caption.
Report a correction
Tell us about an error in this item, its translation, date or attribution. Your contact details stay private and are used only to follow up.